BBI Cambridge Limited
The Biotechnology Business Institute Cambridge or BBI Cambridge is part of an international educational institution specialising in enhancing management skills across the Life Sciences' sector. We develop our students’ knowledge base and commercial understanding in close relationships with multiple industrial partners throughout the Cambridge cluster and across the world.
Our Cambridge Campus is located on the Science Park, just north of historic City of Cambridge, which has a long tradition of inspiring academic knowledge. The City's entrepreneurial roots have attracted global pharmaceutical companies and many start-ups.
Current and future investment in life sciences into the UK enables the development of our students management skills by working with partner companies that support our management programmes. Since 2022, Cambridge has become the BBI's main life sciences' campus and co-ordinates the teaching of the online International MBA in Life Sciences.
BBI Cambridge's location elevates the status of the international business school network to meet a wide range of educational needs of aspiring life scientists throughout their career development.
Where Cambridge meets the world
Products and services
Europe's only MBA focused just on Life Sciences
The Biotechnology Business Institute Cambridge is an established international academic institution focused on delivering bespoke executive education in management for business-focused life scientists. We help accelerate career development into higher management positions in the biopharmaceutical industry and across the wider Life Sciences sector. We offer professional and practical development programmes based on the most relevant areas of effective management practice across the rapidly growing and evolving Life Sciences’ industrial sector. The BBI facilitates career development opportunities for aspiring business development executives with key stakeholders from the biotechnology sector and the pharmaceutical industry worldwide. Our core focus is on commercialising Life Sciences and how to develop a better understanding the latest developments in treating diseases and conditions with unmet medical needs.